Amber Gul, MD
Internal Medicine · Pawtucket, RINPI 1043326978
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 236 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,274, more than ten times the $99 reported in 2021. Among internal medicine clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 236 payments — averaging $24.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$873
- AstraZeneca$795
- Abbott$685
- GSK$402
- Pfizer$329
- Ardelyx, Inc.$237
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,674100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $873 |
| AstraZeneca | 32 | $795 |
| Abbott | 26 | $685 |
| GSK | 18 | $402 |
| Pfizer | 14 | $329 |
| Ardelyx, Inc. | 9 | $237 |
| Novo Nordisk | 11 | $233 |
| Nestle Healthcare Nutrition Inc. | 5 | $228 |
| Gilead | 2 | $178 |
| Bayer | 9 | $148 |
| Vanda Pharmaceuticals Inc. | 5 | $147 |
| Amgen | 6 | $142 |
| Phathom Pharmaceuticals, Inc. | 4 | $126 |
| E.r. Squibb & Sons, L.L.C. | 6 | $124 |
| Exact Sciences | 6 | $119 |
| Inspire Medical Systems, Inc. | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| Johnson & Johnson | 4 | $80 |
| Lundbeck LLC | 3 | $71 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| Novartis | 2 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| Insightec,inc | 1 | $53 |
| Boehringer Ingelheim | 2 | $40 |
| Mylan Specialty L.p. | 2 | $32 |
| Astellas Pharma US Inc | 1 | $31 |
| Eisai Inc. | 1 | $29 |
| Sunovion Pharmaceuticals Inc. | 1 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Boston Scientific | 1 | $22 |
| Merck | 1 | $21 |
| IBSA Pharma Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$237
- ZENPEP$140
How this compares
$5,674 in reported general payments places this provider in the 90th percentile of 808 internal medicine providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 91 | $105,310 |
| EliquisApixaban | 184 | $97,449 |
| XareltoRivaroxaban | 95 | $76,572 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 111 | $75,697 |
| JardianceEmpagliflozin | 92 | $62,126 |
| TrulicityDulaglutide | 44 | $42,197 |
| MyrbetriqMirabegron | 70 | $38,505 |
| FarxigaDapagliflozin Propanediol | 47 | $33,901 |
| JanuviaSitagliptin Phosphate | 46 | $30,005 |
| LinzessLinaclotide | 34 | $21,210 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 82 | $15,175 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 45 | $15,007 |
| Atorvastatin Calcium | 1,105 | $10,659 |
| EntrestoSacubitril/Valsartan | 16 | $10,610 |
| SymbicortBudesonide/Formoterol Fumarate | 42 | $9,632 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $233 | $105,31091 claims |
| PfizerEliquis | $329 | $97,449184 claims |
| Johnson & JohnsonXarelto | $80 | $76,57295 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat | $40 | $76,386120 claims |
| GSKTrelegy Ellipta | $402 | $75,697111 claims |
| AstraZenecaFarxiga, Symbicort, Breztri Aerosphere | $795 | $52,169100 claims |
| Lilly USA, LLCTrulicity | $20 | $42,19744 claims |
| Astellas Pharma US IncMyrbetriq | $31 | $38,50570 claims |
| MerckJanuvia | $21 | $30,00546 claims |
| AbbVieLinzess | $873 | $21,21034 claims |
| NovartisEntresto | $59 | $10,61016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 808 internal medicine providers in Rhode Island.
Other internal medicine in Pawtucket
- Jeffrey BaronPawtucket$19K
- Omeed SaniPawtucket$16K
- Muhammad EhtishamPawtucket$10K
- Rafael Liporaci LucenaPawtucket$4K
- William BeliveauJohnson$951K
- Katarzyna Gilek-SeibertProvidence$131K
- Randall InghamProvidence$100K
- Frank D'alessandroLincoln$93K
- Gregory AllenCranston$38K
- Richard RuggieriProvidence$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.